Dapoxetine Impurity 5
|
達泊西汀雜質(zhì)5
|
2245197-07-1
|
Posaconazole Impurity 20
|
泊沙康唑雜質(zhì)20
|
|
Ticagrelor Related Compound 84
|
替格瑞洛相關化合物84
|
|
Linagliptin Impurity 58
|
利格列汀雜質(zhì)58
|
|
Glycopyrronium Bromide EP Impurity K
|
格隆溴銨EP雜質(zhì)K
|
3900-93-4
|
Linagliptin Impurity 51
|
利格列汀雜質(zhì)51
|
|
Ticagrelor Impurity 28
|
替格瑞洛雜質(zhì)28
|
|
Linagliptin Impurity 31
|
利格列汀雜質(zhì)31
|
|
Ticagrelor Impurity 92
|
替格瑞洛雜質(zhì)92
|
|
Linagliptin Impurity 16
|
利格列汀雜質(zhì)16
|
1911621-52-7
|
Ticagrelor Impurity 69
|
替格瑞洛雜質(zhì)69
|
|
Avibactam Impurity 27
|
阿維巴坦雜質(zhì)27
|
2064219-16-3
|
Linagliptin Impurity 115
|
利格列汀雜質(zhì)115
|
2137744-33-1
|
Posaconazole Impurity 40
|
泊沙康唑雜質(zhì)40
|
1370190-94-5
|
Ticagrelor Impurity 7
|
替格瑞洛雜質(zhì)7
|
|
Dapoxetine Impurity 38
|
達泊西汀雜質(zhì)38
|
693261-93-7
|
Posaconazole Impurity 73
|
泊沙康唑雜質(zhì)73
|
|
N-Nitroso Atomoxetine
|
N-亞硝基托莫西汀
|
|
Baricitinib Impurity 18
|
巴瑞替尼雜質(zhì)18
|
|
Ticagrelor Impurity 89
|
替格瑞洛雜質(zhì)89
|
220352-32-9
|
Linagliptin Diene Impurity
|
利格列汀二烯雜質(zhì)
|
2463617-43-6
|
Ticagrelor Impurity ZY2
|
替格瑞洛雜質(zhì)ZY2
|
2024557-22-8
|
Piperacillin Impurity 21
|
哌拉西林雜質(zhì)21
|
|
Posaconazole Impurity 48
|
泊沙康唑雜質(zhì)48
|
112559-81-6
|
Azithromycin Impurity 23
|
阿奇霉素雜質(zhì)23
|
|
Linagliptin Dimer Impurity 5
|
利格列汀二聚體雜質(zhì)5
|
2253964-85-9
|
Linagliptin Impurity 68
|
利格列汀雜質(zhì)68
|
2436762-89-7
|
Dapoxetine Impurity 18 HCl
|
達泊西汀雜質(zhì)18鹽酸鹽
|
|
Ticagrelor Impurity 34
|
替格瑞洛雜質(zhì)34(THX、LQH的合同以34的名字出16的物質(zhì))
|
|
Piperacillin Impurity 15
|
哌拉西林雜質(zhì)15
|
|
Piperacillin Sodium EP Impurity P
|
哌拉西林鈉EP雜質(zhì)P
|
|
(1E)-1-phenyl-N-(1-phenylethyl)ethanimine
(Posaconazole Impurity ZY4)
|
泊沙康唑雜質(zhì)ZY4
|
42287-40-1
|
Glycopyrrolate Impurity 29
|
格隆溴銨雜質(zhì)29
|
124065-56-1
|
Dapoxetine Impurity 37
|
達泊西汀雜質(zhì)37
|
861380-44-1
|
Ticagrelor Related Compound 105
|
替格瑞洛相關化合物105
|
|
Dapoxetine Impurity ZY8
|
達泊西汀雜質(zhì)ZY8
|
|
N-Nitroso Ticagrelor Impurity 65
|
N-亞硝基替格瑞洛雜質(zhì) 65
|
|
N-Nitroso-N-Desmethyl Dapoxetine
|
N-硝基-N-去甲基達泊西汀
|
|
Ticagrelor Impurity 58 HCl
|
替格瑞洛雜質(zhì) 58鹽酸鹽
|
|
Posaconazole Impurity 96
|
泊沙康唑雜質(zhì)96
|
|
Lidocaine Monohydrate EP Impurity K
|
利多卡因一水合物EP雜質(zhì)K
|
74634-66-5
|
Linagliptin Impurity 77
|
利格列汀雜質(zhì)77
|
|
Chlorhexidine Digluconate Impurity 3
|
氯己定二葡糖酸鹽雜質(zhì)3
|
|
Posaconazole Impurity 124 DiHCl
|
泊沙康唑雜質(zhì)124二鹽酸
|
|
Glycopyrronium Bromide EP Impurity I Bromide (RS-Isomer) (Glycopyrrolate USP Related Compound I (RS-Isomer))
|
格隆溴銨EP雜質(zhì)I溴化物(RS-異構體)
|
|
Risperidone Impurity 21 HCl
|
利培酮雜質(zhì)21HCl
|
|
Avibactam Impurity ZY1
|
阿維巴坦雜質(zhì)ZY1
|
|
Linagliptin Impurity 88
|
利格列汀雜質(zhì)88
|
|
Linagliptin Impurity 100
|
利格列汀雜質(zhì)100
|
|
Piperacillin Impurity 33 Sodium Salt
|
哌拉西林雜質(zhì)33鈉鹽
|
|
Risperidone Impurity 4 HCl
|
利培酮雜質(zhì)4鹽酸鹽
|
106266-04-0
|
(1R,2R)-2-(2,6-Difluorophenyl)cyclopropanamine
|
(1R,2R)-2-(2,6-二氟苯基)環(huán)丙胺
|
|
(1S,2R)-2-(2,5-difluorophenyl)cyclopropanamine
|
(1S,2R)-2-(2,5-二氟苯基)環(huán)丙胺
|
|
Ticagrelor Related Compound 72
|
替格瑞洛相關雜質(zhì)72
|
145783-14-8
|
Ticagrelor EP Impurity E Mandelate
|
替格瑞洛EP雜質(zhì)E扁桃酸鹽
|
|
Atomoxetine Impurity 9 HCl
|
托莫西汀雜質(zhì)9鹽酸鹽
|
1011-59-2
|
Benzylposaconazole
|
芐基泊沙康唑
|
170985-86-1
|
Posaconazole Impurity 107
|
泊沙康唑雜質(zhì)107
|
|
N-Formyl (R)-Octabase (Mixture of Diastereomers)
|
N-甲酰基(R)-辛堿(非對映體混合物)
|
51773-23-0
|
Ticagrelor Impurity 48
|
替格瑞洛雜質(zhì) 48
|
274693-26-4
|
Glycopyrronium Bromide EP Impurity H
|
格隆溴銨EP雜質(zhì)H
|
15206-55-0
|
Posaconazole Impurity 126
|
泊沙康唑雜質(zhì)126
|
|
Ticagrelor Impurity 4
|
替格瑞洛雜質(zhì)4
|
1345413-20-8
|
Ticagrelor Impurity 99
|
替格瑞洛雜質(zhì)99
|
376608-75-2
|
Azithromycin Impurity 24
|
阿奇霉素雜質(zhì)24
|
|
Baricitinib Impurity 28
|
巴瑞替尼雜質(zhì)28
|
|
Posaconazole Impurity 60
|
泊沙康唑雜質(zhì)60
|
|
rac-Dapoxetine Impurity 20
|
達泊西汀雜質(zhì)20消旋體
|
1445281-25-3
|
Risperidone Impurity 2
|
利培酮雜質(zhì)2
|
|
Posaconazole Impurity 54
|
泊沙康唑雜質(zhì)54
|
|
Azithromycin Impurity 5
|
阿奇霉素雜質(zhì)5
|
|
Linagliptin Impurity 47
|
利格列汀雜質(zhì)47
|
2074688-84-7
|
Ticagrelor Related Compound 19
|
替格瑞洛相關化合物19
|
2378409-07-3
|
Posaconazole Impurity 108
|
泊沙康唑雜質(zhì)108
|
|
Chlorhexidine EP Impurity A HCl
|
氯己定EP雜質(zhì)A HCl
|
152504-08-0
|
Ticagrelor Impurity 25
|
替格瑞洛雜質(zhì)25
|
|
Ticagrelor Related Compound 81
|
替格瑞洛相關化合物81
|
|
Posaconazole Impurity 36
|
泊沙康唑雜質(zhì)36
|
|
Ticagrelor Related Compound 12
|
替格瑞洛相關化合物12
|
|
Ticagrelor Impurity 118
|
替格瑞洛雜質(zhì)118
|
1402150-27-9
|
Linagliptin Impurity 46
|
利格列汀雜質(zhì)46
|
|
Tedizolid Phosphate N-Oxide
|
磷酸特地唑胺氮氧化物
|
2095200-68-1
|
Glycopyrrolate Impurity 17 Bromide
|
格隆溴銨雜質(zhì)17溴化物
|
1404453-68-4
|
Ticagrelor Impurity 20
|
替格瑞洛雜質(zhì)20
|
|
Tedizolid Impurity 57
|
特地唑胺雜質(zhì)57
|
656-65-5
|
Desfluoro Posaconazole
|
去氟泊沙康唑
|
|
Linagliptin Impurity 39
|
利格列汀雜質(zhì)39
|
|
Posaconazole Impurity 21
|
泊沙康唑雜質(zhì)21
|
171228-50-5
|
Posaconazole Diastereoisomer 11 (S,S,S,R)
|
泊沙康唑非對映異構體11(S,S,S、R)
|
|
Tedizolid Impurity 58
|
特地唑胺雜質(zhì)58
|
510729-01-8
|
Ticagrelor Related Compound 86
|
替格瑞洛相關化合物86
|
|
Linagliptin Impurity 60
|
利格列汀雜質(zhì)60
|
13535-91-6
|
Dapoxetine Impurity 32
|
達泊西汀雜質(zhì)32
|
38262-42-9
|
Ticagrelor Impurity 32
|
替格瑞洛雜質(zhì) 32
|
220241-60-1
|
Posaconazole Impurity 7
|
泊沙康唑雜質(zhì)7
|
345217-02-9
|
Posaconazole Impurity 31
|
泊沙康唑雜質(zhì)31
|
|
Posaconazole Impurity 10 (POS-A)
|
泊沙康唑雜質(zhì)10(POS-A)
|
|
Chlorhexidine Digluconate (solution in water)
|
二葡糖酸氯己定(水溶液)
|
18472-51-0
|
Linagliptin Metabolite CD1790
|
利格列汀CD1790代謝產(chǎn)物
|
1620278-39-8
|
Linagliptin Impurity 75
|
利格列汀雜質(zhì)75
|
586408-08-4
|